Atlas Trials

A Study of TQB3455 Tablets in Subjects With Advanced Malignancies

Clinical trial NCT04340427 · UNKNOWN

Trial details

NCT number
NCT04340427
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Malignancies
Start date
2020-04-10
Primary completion
2021-06-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.